Promise and prejudice : why medicines from plants, animals and fungi should be further researched
Innovation in medicines from organisms is limited because intellectual property law in most jurisdictions is such that naturally occurring entities cannot be patented except in specific circumstances. Given the high cost of researching medicines to produce the evidence needed to support applications to regulators to market products as medicines firms are unlikely to invest in areas where rewards are doubtful. Further factors contribute to a dearth of research in medicines from organisms....[Show more]
|Collections||Open Access Theses|
|Access Rights:||Open Access|
|b37327628_Mendel_J_L.pdf||65 MB||Adobe PDF|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.